Fundinno
VC Fund
Higashi-shinagawa, Japan
Fundinno is an equity investment crowdfunding platform.
- Total investments:
- 100
- Last investment:
- Lead investor:
- 70%
Last updated:
For AI agents: llms.txt
Industries Fundinno invests in
Stages Fundinno invests in
Countries Fundinno invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Equity Crowdfunding
- $131k–$582k
- Product Crowdfunding
- $123k–$444k
Investment Focus
Industry
- Information Technology 13 (13%)
- Content 8 (8%)
- Health Care 8 (8%)
- Beauty 7 (7%)
- Media and Entertainment 7 (7%)
Stage
- Equity Crowdfunding 44 (44%)
- Product Crowdfunding 10 (10%)
- Funding Round 8 (8%)
- Seed 6 (6%)
- Angel 4 (4%)
Country
- Japan 68 (68%)
- France 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Yuki Shibahara
Founder
|
Founder | Total investments: 2 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| FUNDiT is an IT-focused M&A and business consolidation company that specializes in acquiring, managing, and scaling IT companies. | Series D / May 11, 2026 | ||
| Atto operates in the healthcare and preventive medicine field as a technology venture. Its main business is the development, manufacturing, and sale of health inspection equipment. The core product is a capillary blood flow observation device called Kekkan Bijin. This device allows users to observe capillary blood flow simply by placing a finger onit, without any blood sampling. | $114.2K / Equity Crowdfunding / Feb 19, 2026 | ||
| Novius, Inc. is a Japan-based medical technology startup developing advanced glass-free 3D endoscopic imaging solutions. Its flagship platform, N-Vision3D, enables real-time 2D-to-3D conversion of endoscopic and microscopic images using proprietary AI-powered depth estimation. By enhancing depth perception without requiring specialized 3Dendoscopes, Novius improves surgical accuracy, supports medical training, and expands accessibility to next-generation imaging worldwide. Developed proprietary real-time 2D-to-3D imaging technology compatible with existing Olympus endoscopy towers and monitors.Completed initial clinical adoption with early users in Japan.Expanding global commercialization in minimally invasive surgery, cancer treatment, and medical education. | $330K / Series A / Oct 24, 2025 | ||
| LocationMind is an IT company that provides human flow analysis, IoT solutions, and security for positioning signals. Through AI analysis of location information and big data, they provide end-to-end services to customers in a variety of fields. A position critical to the advancement of next-generation technology. They have independently developedmultiple AI models that specialize in people flow to make predictions for the near future, in addition to analyzing people flow in the past. | $5.7M / Series B / Sep 30, 2025 | ||
| B dot Medical is creating an ultra-compact proton cancer therapy device to improve care for all and add to society through radiotherapy. | $7M / Venture - Series Unknown / Aug 20, 2025 | ||
| LocationMind is an IT company that provides human flow analysis, IoT solutions, and security for positioning signals. Through AI analysis of location information and big data, they provide end-to-end services to customers in a variety of fields. A position critical to the advancement of next-generation technology. They have independently developedmultiple AI models that specialize in people flow to make predictions for the near future, in addition to analyzing people flow in the past. | Series B / Jul 15, 2025 | ||
| Innovacell is a biotechnology firm entirely focused on the area of tissue engineering and it operates one of Europe's largest and most modern production facilities for the proliferation of the body's own tissue cells. Its supervisory board is chaired by the experienced financial expert, Dr. Harald Pöttinger, a director of Alpine EquityManagement AG, based in Bregenz, Austria. Innovacell currently employs 20 staff as well as numerous outside experts. | $10.1M / Series D / Dec 27, 2024 | ||
| ASIAN BRIDGE is a one-stop-shop for Japanese merchandise such as beauty care products, health foods, and clothing. The company was founded in 2010 and is based in Tokyo, Japan. | $6.2M / Venture - Series Unknown / Jul 19, 2024 | ||
| Cricket Farm is a food manufacturing company that produces and retails a wide range of eco-friendly and protein-rich insect food products. | $292K / Debt Financing / Nov 17, 2022 | ||
| Cricket Farm is a food manufacturing company that produces and retails a wide range of eco-friendly and protein-rich insect food products. | $227.9K / Equity Crowdfunding / Nov 17, 2022 | ||
| See all 100 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Fundinno invest in?
Fundinno invests primarily in Information Technology, Content and Health Care startups, most often at Equity Crowdfunding and Product Crowdfunding stage. Most of the 100 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Fundinno's check size?
Fundinno typically joins rounds of $131k–$582k at Equity Crowdfunding and $123k–$444k at Product Crowdfunding. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Fundinno participates in.
How do I contact Fundinno?
Public channels for Fundinno include X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Fundinno?
The team at Fundinno includes Yuki Shibahara (Founder). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
